Diabetic
gastroparesis (DGP) is a common complication in
patients with
diabetes mellitus of long duration, presenting with recurrent
nausea,
vomiting, postprandial fullness and early satiety caused by delayed
gastric emptying. The
treatments of DGP include dietary
therapy,
nutritional support,
glycemic control, use of prokinetic and
antiemetic agents. This
review focuses on current status of the
drug treatment and the progress of new agents of DGF under the preclinical and clinical trials.